[H]C12CC([H])(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4([H])C(O)C(C)=CC([H])(C(=O)O1)C34O)OC1(CCC(C)C([H])(C(C)C)O1)C2.[H]C12CC([H])(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4([H])C(O)C(C)=CC([H])(C(=O)O1)C34O)OC1(CCC(C)C([H])(C(C)CC)O1)C2
Rewrite: DRUGMATRIX assay uses AB-MECA as a ligand for Adenosine A2A radioligand binding. The assay focuses on a single protein target and uses HEK293 cells and membrane fraction in vitro for binding analysis. Does the molecule work for this test?